Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Influenza

  Free Subscription


21.04.2020

1 Antimicrob Agents Chemother
1 Antiviral Res
1 Arch Virol
6 BMJ
1 Cell
1 J Exp Med
1 J Infect Dis
2 J Virol
1 JAMA
1 Lancet
4 Lancet Gastroenterol Hepatol
5 MMWR Morb Mortal Wkly Rep
3 N Engl J Med
1 PLoS Comput Biol
1 PLoS Med
1 PLoS One
4 Proc Natl Acad Sci U S A
3 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. NGUYEN CT, Suzuki S, Itoh Y, Ishigaki H, et al
    Efficacy of neuraminidase inhibitors against H5N6 highly pathogenic avian influenza virus in a non-human primate model.
    Antimicrob Agents Chemother. 2020 Apr 13. pii: AAC.02561.
    PubMed         Abstract available


    Antiviral Res

  2. LAURE M, Hamza H, Koch-Heier J, Quernheim M, et al
    Antiviral efficacy against Influenza virus and pharmacokinetic analysis of a novel MEK-inhibitor, ATR-002, in cell culture and in the mouse model.
    Antiviral Res. 2020 Apr 15:104806. doi: 10.1016/j.antiviral.2020.104806.
    PubMed         Abstract available


    Arch Virol

  3. YEHIA N, Hassan WMM, Sedeek A, Elhusseiny MH, et al
    Genetic variability of avian influenza virus subtype H5N8 in Egypt in 2017 and 2018.
    Arch Virol. 2020 Apr 13. pii: 10.1007/s00705-020-04621.
    PubMed         Abstract available


    BMJ

  4. BEECHING NJ, Fletcher TE, Beadsworth MBJ
    Covid-19: testing times.
    BMJ. 2020;369:m1403.
    PubMed        

  5. FERNER RE, Aronson JK
    Chloroquine and hydroxychloroquine in covid-19.
    BMJ. 2020;369:m1432.
    PubMed        

  6. GREENHALGH T, Schmid MB, Czypionka T, Bassler D, et al
    Face masks for the public during the covid-19 crisis.
    BMJ. 2020;369:m1435.
    PubMed        

  7. JAVID B, Weekes MP, Matheson NJ
    Covid-19: should the public wear face masks?
    BMJ. 2020;369:m1442.
    PubMed        

  8. POLLOCK AM, Clements L, Harding-Edgar L
    Covid-19: why we need a national health and social care service.
    BMJ. 2020;369:m1465.
    PubMed        

  9. SPERRIN M, Grant SW, Peek N
    Prediction models for diagnosis and prognosis in Covid-19.
    BMJ. 2020;369:m1464.
    PubMed        


    Cell

  10. WANDZIK JM, Kouba T, Karuppasamy M, Pflug A, et al
    A Structure-Based Model for the Complete Transcription Cycle of Influenza Polymerase.
    Cell. 2020 Apr 16. pii: S0092-8674(20)30389-5. doi: 10.1016/j.cell.2020.
    PubMed         Abstract available


    J Exp Med

  11. PROKUNINA-OLSSON L, Alphonse N, Dickenson RE, Durbin JE, et al
    COVID-19 and emerging viral infections: The case for interferon lambda.
    J Exp Med. 2020;217.
    PubMed         Abstract available


    J Infect Dis

  12. ACKERSON B, An J, Sy LS, Solano Z, et al
    Cost of Hospitalization Associated with Respiratory Syncytial Virus Infection Versus Influenza Infection in Hospitalized Older Adults.
    J Infect Dis. 2020 Apr 17. pii: 5821154. doi: 10.1093.
    PubMed         Abstract available


    J Virol

  13. WALKER AP, Sharps J, Fodor E
    Mutation of an influenza virus polymerase 3' RNA promoter binding site inhibits transcription elongation.
    J Virol. 2020 Apr 15. pii: JVI.00498-20. doi: 10.1128/JVI.00498.
    PubMed         Abstract available

  14. WIGNALL-FLEMING EB, Vasou A, Young D, Short JAL, et al
    Innate intracellular antiviral responses restrict the amplification of defective virus genomes of Parainfluenza Virus type 5.
    J Virol. 2020 Apr 15. pii: JVI.00246-20. doi: 10.1128/JVI.00246.
    PubMed         Abstract available


    JAMA


  15. The Prevailing Pandemic of Influenza.
    JAMA. 2020;323:1414-1415.
    PubMed        


    Lancet

  16. MEMISH ZA, Ahmed QA, Schlagenhauf P, Doumbia S, et al
    No time for dilemma: mass gatherings must be suspended.
    Lancet. 2020;395:1191-1192.
    PubMed        


    Lancet Gastroenterol Hepatol

  17. WU Y, Guo C, Tang L, Hong Z, et al
    Prolonged presence of SARS-CoV-2 viral RNA in faecal samples.
    Lancet Gastroenterol Hepatol. 2020 Mar 19. pii: S2468-1253(20)30083.
    PubMed        

  18. ZHANG C, Shi L, Wang FS
    Liver injury in COVID-19: management and challenges.
    Lancet Gastroenterol Hepatol. 2020 Mar 4. pii: S2468-1253(20)30057.
    PubMed        

  19. MAO R, Liang J, Shen J, Ghosh S, et al
    Implications of COVID-19 for patients with pre-existing digestive diseases.
    Lancet Gastroenterol Hepatol. 2020 Mar 11. pii: S2468-1253(20)30076.
    PubMed        

  20. IANIRO G, Mullish BH, Kelly CR, Sokol H, et al
    Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel.
    Lancet Gastroenterol Hepatol. 2020 Mar 16. pii: S2468-1253(20)30082.
    PubMed        


    MMWR Morb Mortal Wkly Rep

  21. LASRY A, Kidder D, Hast M, Poovey J, et al
    Timing of Community Mitigation and Changes in Reported COVID-19 and Community Mobility - Four U.S. Metropolitan Areas, February 26-April 1, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:451-457.
    PubMed         Abstract available

  22. GHINAI I, Woods S, Ritger KA, McPherson TD, et al
    Community Transmission of SARS-CoV-2 at Two Family Gatherings - Chicago, Illinois, February-March 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:446-450.
    PubMed         Abstract available


  23. Characteristics of Health Care Personnel with COVID-19 - United States, February 12-April 9, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:477-481.
    PubMed         Abstract available

  24. HEINZERLING A, Stuckey MJ, Scheuer T, Xu K, et al
    Transmission of COVID-19 to Health Care Personnel During Exposures to a Hospitalized Patient - Solano County, California, February 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:472-476.
    PubMed         Abstract available


  25. Geographic Differences in COVID-19 Cases, Deaths, and Incidence - United States, February 12-April 7, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:465-471.
    PubMed         Abstract available


    N Engl J Med

  26. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Emerging Tools in the Fight against Covid-19.
    N Engl J Med. 2020;382:e39.
    PubMed        

  27. PARMET WE, Sinha MS
    Covid-19 - The Law and Limits of Quarantine.
    N Engl J Med. 2020 Mar 18. doi: 10.1056/NEJMp2004211.
    PubMed        

  28. NG OT, Marimuthu K, Chia PY, Koh V, et al
    SARS-CoV-2 Infection among Travelers Returning from Wuhan, China.
    N Engl J Med. 2020 Mar 12. doi: 10.1056/NEJMc2003100.
    PubMed        


    PLoS Comput Biol

  29. QUIROUETTE C, Younis NP, Reddy MB, Beauchemin CAA, et al
    A mathematical model describing the localization and spread of influenza A virus infection within the human respiratory tract.
    PLoS Comput Biol. 2020;16:e1007705.
    PubMed         Abstract available


    PLoS Med

  30. SHEARER FM, Moss R, McVernon J, Ross JV, et al
    Infectious disease pandemic planning and response: Incorporating decision analysis.
    PLoS Med. 2020;17:e1003018.
    PubMed         Abstract available


    PLoS One

  31. MOA AM, Muscatello DJ, Turner RM, MacIntyre CR, et al
    Estimated hospitalisations attributable to seasonal and pandemic influenza in Australia: 2001- 2013.
    PLoS One. 2020;15:e0230705.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  32. NEWMAN JH, Chesson CB, Herzog NL, Bommareddy PK, et al
    Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer.
    Proc Natl Acad Sci U S A. 2020;117:1119-1128.
    PubMed         Abstract available

  33. MATSUYAMA S, Nao N, Shirato K, Kawase M, et al
    Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells.
    Proc Natl Acad Sci U S A. 2020;117:7001-7003.
    PubMed         Abstract available

  34. WELLS CR, Sah P, Moghadas SM, Pandey A, et al
    Impact of international travel and border control measures on the global spread of the novel 2019 coronavirus outbreak.
    Proc Natl Acad Sci U S A. 2020;117:7504-7509.
    PubMed         Abstract available

  35. YEH YT, Gulino K, Zhang Y, Sabestien A, et al
    A rapid and label-free platform for virus capture and identification from clinical samples.
    Proc Natl Acad Sci U S A. 2020;117:895-901.
    PubMed         Abstract available


    Vaccine

  36. CROSS JW, Joy M, McGee C, Akinyemi O, et al
    Adverse events of interest vary by influenza vaccine type and brand: Sentinel network study of eight seasons (2010-2018).
    Vaccine. 2020 Apr 13. pii: S0264-410X(20)30402.
    PubMed         Abstract available

  37. STAPLETON JT, Wagner N, Tuetken R, Bellamy AR, et al
    High dose trivalent influenza vaccine compared to standard dose vaccine in patients with rheumatoid arthritis receiving TNF-alpha inhibitor therapy and healthy controls: Results of the DMID 10-0076 randomized clinical trial.
    Vaccine. 2020 Apr 12. pii: S0264-410X(20)30459.
    PubMed         Abstract available

  38. CHANG CY, Cho CY, Lai CC, Lu CY, et al
    Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in healthy subjects aged 3 to 17 years old: A phase III, open label, single-arm study.
    Vaccine. 2020 Apr 10. pii: S0264-410X(20)30437.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: